Marginprobe Probe
Device Margin Assessment
PDI 07290012534034
General payments
$73,949
Research payments
$354,078
Through program year 2024, $73,949 in general payments and $354,078 in research payments were reported against Marginprobe Probe (Margin Assessment).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $227,526 | 32 |
| 2023 | Research | $60,726 | 9 |
| 2022 | General | $6,366 | 32 |
| 2022 | Research | $14,900 | 5 |
| 2021 | General | $67,582 | 33 |
| 2021 | Research | $50,926 | 2 |
Breakdown
The top 5 of 31 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
65 general · 48 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.